IDENTIFICATION OF TRICYCLIC ANALOGS RELATED TO ELLAGIC ACID AS POTENT SELECTIVE TYROSINE PROTEIN-KINASE INHIBITORS

被引:39
|
作者
DOW, RL [1 ]
CHOU, TT [1 ]
BECHLE, BM [1 ]
GODDARD, C [1 ]
LARSON, ER [1 ]
机构
[1] ONCOGENE SCI INC,MANHASSET,NY 11030
关键词
D O I
10.1021/jm00040a015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The plant-derived natural product ellagic acid (1) has recently been identified as a potent, though nonselective, inhibitor of the tyrosine-specific protein kinase pp60(src). This report details efforts directed toward the identification of tricyclic structures related to ellagic acid, with enhanced specificity for inhibition of pp60(src) over other protein kinases. Phenanthridinone and carbazole core structures were selected for investigation, since N-functionalization allows for the synthesis of numerous analogs which can be utilized to probe enzyme-inhibitor interactions. These ring systems were prepared via a general sequence of biaryl bond formation followed by cyclization to form the desired tricyclic ring systems. N-Alkylation, -acylation, or -sulfonylation and deprotection with boron tribromide afford the target tetraphenolic phenanthridinones 5 and carbazoles 9. Several analogs from both of these series have potencies comparable to that of 1 and exhibit substantially enhanced selectivities for inhibition of pp60(src) relative to protein kinase A (PKA), a serine/threonine protein kinase. Carbazole-based analogs 9j,m,p are submicromolar inhibitors of pp60(src), with potency for the target tyrosine kinase comparable to that of ellagic acid (1), however with 2 orders of magnitude greater selectivity versus that for PKA. As seen for ellagic acid, members of the phenanthridinone-based series (e.g., 5a) exhibited inhibition of pp60(src) in a manner which is partial mixed noncompetitive with respect to ATP, while analogs in the carbazole series (e.g., 9a) inhibit pp60(src) in an ATP competitive manner.
引用
收藏
页码:2224 / 2231
页数:8
相关论文
共 50 条
  • [1] MOLECULAR DESIGN AND BIOLOGICAL-ACTIVITY OF POTENT AND SELECTIVE PROTEIN-KINASE INHIBITORS RELATED TO BALANOL
    KOIDE, K
    BUNNAGE, ME
    PALOMA, LG
    KANTER, JR
    TAYLOR, SS
    BRUNTON, LL
    NICOLAOU, KC
    CHEMISTRY & BIOLOGY, 1995, 2 (09): : 601 - 608
  • [2] Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase
    Battisti, Umberto Maria
    Gao, Chunixa
    Akladios, Fady
    Kim, Woonghee
    Yang, Hong
    Bayram, Cemil
    Bolat, Ismail
    Kiliclioglu, Metin
    Yuksel, Nursena
    Tozlu, Ozlem Ozdemir
    Zhang, Cheng
    Sebhaoui, Jihad
    Iqbal, Shazia
    Shoaie, Saeed
    Hacimuftuoglu, Ahmet
    Yildirim, Serkan
    Turkez, Hasan
    Uhlen, Mathias
    Boren, Jan
    Mardinoglu, Adil
    Grotli, Morten
    NUTRIENTS, 2023, 15 (03)
  • [3] Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties
    Wang, Xiaojing
    Barbosa, James
    Blomgren, Peter
    Bremer, Meire C.
    Chen, Jacob
    Crawford, James J.
    Deng, Wei
    Dong, Liming
    Eigenbrot, Charles
    Gallion, Steve
    Hau, Jonathon
    Hu, Huiyong
    Johnson, Adam R.
    Katewa, Arna
    Kropf, Jeffrey E.
    Lee, Seung H.
    Liu, Lichuan
    Lubach, Joseph W.
    Macaluso, Jen
    Maciejewski, Pat
    Mitchell, Scott A.
    Ortwine, Daniel F.
    DiPaolo, Julie
    Reif, Karin
    Scheerens, Heleen
    Schmitt, Aaron
    Wong, Harvey
    Xiong, Jin-Ming
    Xu, Jianjun
    Zhao, Zhongdong
    Zhou, Fusheng
    Currie, Kevin S.
    Young, Wendy B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (06): : 608 - 613
  • [4] Identification and characterization of novel, potent, and selective inhibitors of protein kinase
    Sharlow, Elizabeth R.
    Wipf, Peter
    Wang, Jane
    Lazo, John S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [5] Identification of Potent and Selective Amidobipyridyl Inhibitors of Protein Kinase D
    Meredith, Erik L.
    Beattie, Kimberly
    Burgis, Robin
    Capparelli, Michael
    Chapo, Joseph
    DiPietro, Lucian
    Gamber, Gabriel
    Enyedy, Istvan
    Hood, David B.
    Hosagrahara, Vinayak
    Jewell, Charles
    Koch, Keith A.
    Lee, Wendy
    Lemon, Douglas D.
    McKinsey, Timothy A.
    Miranda, Karl
    Pagratis, Nikos
    Phan, Dillon
    Plato, Craig
    Rao, Chang
    Rozhitskaya, Olga
    Soldermann, Nicolas
    Springer, Clayton
    van Eis, Maurice
    Vega, Richard B.
    Yan, Wanlin
    Zhu, Qingming
    Monovich, Lauren G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (15) : 5422 - 5438
  • [6] NONAMINE-CONTAINING BICYCLIC AND TRICYCLIC ANALOGS OF LAVENDUSTIN A AS PROTEIN-TYROSINE KINASE INHIBITORS
    SMYTH, MS
    STEFANOVA, I
    HARTMANN, F
    HORAK, ID
    OSHEROV, N
    LEVITZKI, A
    BURKE, TR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 107 - MEDI
  • [7] INHIBITION OF TYROSINE PROTEIN-KINASE BY SYNTHETIC ERBSTATIN ANALOGS
    ISSHIKI, K
    IMOTO, M
    SAWA, T
    UMEZAWA, K
    TAKEUCHI, T
    UMEZAWA, H
    TSUCHIDA, T
    YOSHIOKA, T
    TATSUTA, K
    JOURNAL OF ANTIBIOTICS, 1987, 40 (08): : 1209 - 1210
  • [8] Identification of novel imidazole flavonoids as potent and selective inhibitors of protein tyrosine phosphatase
    Zhang, Ling
    Ge, Yu
    Wang, Qing Ming
    Zhou, Cheng-He
    BIOORGANIC CHEMISTRY, 2019, 88
  • [9] INVOLVEMENT OF PROTEIN-KINASE IN INDUCTION OF TYROSINE AMINOTRANSFERASE BY CAMP ANALOGS
    WIMALASENA, J
    LEICHTLING, BH
    SU, MYF
    WICKS, WD
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 737 - 737
  • [10] IDENTIFICATION OF A NEW INVITRO SUBSTRATE OF TYROSINE PROTEIN-KINASE
    TOKUDA, M
    KONG, SK
    KHANNA, NC
    WAISMAN, DM
    BIOCHEMISTRY, 1987, 26 (17) : 5226 - 5229